Variant Summary
- Also known as
- GLN61
- HGVS
- —
- Variant Type(s)
- missense_variant
- Evidence Items
- 8
Evidence Level Distribution
Level B: 7Level C: 1
Evidence Items
Showing CIViC evidence rows where gene = NRAS and variant = Q61.
| Level | Type | Direction | Significance | Disease | Drugs | Rating |
|---|---|---|---|---|---|---|
| B | Predictive | Supports | Resistance | Melanoma | Vemurafenib | 4 |
| B | Diagnostic | Supports | Positive | Melanoma | 3 | |
| B | Predictive | Does Not Support | Resistance | Colorectal Cancer | Cetuximab | 3 |
| B | Prognostic | Supports | Follicular Thyroid Carcinoma | 3 | ||
| B | Predictive | Supports | Sensitivity/Response | Skin Melanoma | Binimetinib | 2 |
| C | Predictive | Supports | Sensitivity/Response | Skin Melanoma | Selumetinib | 2 |
| B | Predictive | Supports | Resistance | Colorectal Cancer | Cetuximab,Chemotherapy | 2 |
| B | Prognostic | Does Not Support | Poor Outcome | Follicular Thyroid Carcinoma | 2 |